Allison Coker - Publications
Affiliations: | University of California, San Francisco, San Francisco, CA |
Area:
addiction, reinforcement, stressYear | Citation | Score | |||
---|---|---|---|---|---|
2022 | Henningfield JE, Coe MA, Griffiths RR, Belouin SJ, Berger A, Coker AR, Comer SD, Heal DJ, Hendricks PS, Nichols CD, Sapienza F, Vocci FJ, Zia FZ. Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling. Neuropharmacology. 109220. PMID 35987353 DOI: 10.1016/j.neuropharm.2022.109220 | 0.256 | |||
2020 | Coker AR, Weinstein DN, Vega TA, Miller CS, Kayser AS, Mitchell JM. The catechol-O-methyltransferase inhibitor tolcapone modulates alcohol consumption and impulsive choice in alcohol use disorder. Psychopharmacology. PMID 32617646 DOI: 10.1007/s00213-020-05599-5 | 0.501 | |||
2014 | Mitchell JM, Margolis EB, Coker AR, Allen DC, Fields HL. Intra-VTA deltorphin, but not DPDPE, induces place preference in ethanol-drinking rats: distinct DOR-1 and DOR-2 mechanisms control ethanol consumption and reward. Alcoholism, Clinical and Experimental Research. 38: 195-203. PMID 24033469 DOI: 10.1111/Acer.12246 | 0.595 | |||
2012 | Mitchell JM, Margolis EB, Coker AR, Fields HL. Alcohol self-administration, anxiety, and cortisol levels predict changes in delta opioid receptor function in the ventral tegmental area. Behavioral Neuroscience. 126: 515-22. PMID 22708955 DOI: 10.1037/a0029027 | 0.606 | |||
2012 | Mitchell JM, Grossman LE, Coker AR, Messing RO. The anticonvulsant levetiracetam potentiates alcohol consumption in non-treatment seeking alcohol abusers. Journal of Clinical Psychopharmacology. 32: 269-72. PMID 22367657 DOI: 10.1097/JCP.0b013e318248ba69 | 0.517 | |||
2010 | Margolis EB, Coker AR, Driscoll JR, Lemaître AI, Fields HL. Reliability in the identification of midbrain dopamine neurons. Plos One. 5: e15222. PMID 21151605 DOI: 10.1371/journal.pone.0015222 | 0.578 | |||
Show low-probability matches. |